ReShape Lifesciences News - RSLS

Company Name	Stock Ticker Symbol	Market	Type
ReShape Lifesciences Inc	RSLS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.1669	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.1669

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/01/2024	16:05	GLOBE	ReShape Lifesciences® Reports Year Ended December 31, 2023..
3/28/2024	08:31	GLOBE	ReShape Lifesciences® Receives Notice of Allowance for..
3/04/2024	08:31	GLOBE	ReShape Lifesciences® Provides Update on 2024 Cost Reduction..
2/26/2024	16:19	EDGAR2	Form 8-K - Current report
2/22/2024	08:31	GLOBE	ReShape Lifesciences® Announces First Surgeries Utilizing..
1/24/2024	08:31	GLOBE	ReShape Lifesciences® Conducts Bariatric Fellows Training..
1/18/2024	16:38	EDGAR2	Form 8-K - Current report
1/16/2024	18:11	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
1/05/2024	16:14	EDGAR2	Form PRE 14A - Other preliminary proxy statements
12/20/2023	08:31	GLOBE	ReShape Lifesciences® Engages Maxim Group LLC To Identify..
12/12/2023	16:05	GLOBE	ReShape Lifesciences® Receives FDA PMA Supplement Approval..
11/29/2023	16:05	EDGAR2	Form 8-K - Current report
11/21/2023	08:06	GLOBE	ReShape Lifesciences® Enters into Warrant Exercise..
11/08/2023	16:05	GLOBE	ReShape Lifesciences® Reports Third Quarter Ended September..
11/06/2023	08:31	GLOBE	ReShape Lifesciences® to Announce Financial Results for the..
10/13/2023	16:42	EDGAR2	Form 8-K - Current report
10/05/2023	16:05	EDGAR2	Form 8-K - Current report
10/03/2023	09:23	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
9/29/2023	12:30	GLOBE	ReShape Lifesciences® Announces Pricing of $3.0 Million..
9/27/2023	17:30	EDGAR2	Form S-1/A - General form for registration of securities..
9/22/2023	16:02	EDGAR2	Form 8-K - Current report
9/22/2023	08:31	GLOBE	ReShape Lifesciences® Announces Participation in the LD..
9/21/2023	08:31	GLOBE	ReShape Lifesciences® Signs Exclusive License Agreement With..
9/19/2023	08:31	GLOBE	ReShape Lifesciences® Significantly Strengthens Patent..
9/14/2023	08:31	GLOBE	ReShape Lifesciences® Receives NIH SBIR Grant to Further..
8/25/2023	16:41	EDGAR2	Form S-1 - General form for registration of securities under..
8/07/2023	17:26	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	16:54	EDGAR2	Form 8-K - Current report
8/07/2023	16:05	GLOBE	ReShape Lifesciences® Reports Second Quarter Ended June 30,..
8/03/2023	16:05	GLOBE	ReShape Lifesciences® to Announce Financial Results for the..
6/29/2023	08:31	GLOBE	ReShape Lifesciences® Signs Preferred Partner Agreement With..
6/28/2023	08:31	GLOBE	ReShape Lifesciences® Presents Data on its Proprietary..
6/26/2023	16:05	GLOBE	ReShape Lifesciences® Submits FDA PMA Supplement Application..
6/23/2023	08:35	GLOBE	Life Science Investor Forum: Presentations Now Available for..
6/20/2023	10:58	GLOBE	Life Science Investor Forum Agenda Announced for June 22nd
6/14/2023	08:31	GLOBE	ReShape Lifesciences® to Participate in Investor and..
5/15/2023	16:05	GLOBE	ReShape Lifesciences® Reports First Quarter Ended March 31,..
5/11/2023	08:30	GLOBE	ReShape Lifesciences® to Announce Financial Results for the..
4/27/2023	08:30	GLOBE	ReShape Lifesciences® to Present Data on its Proprietary..
4/25/2023	16:05	GLOBE	ReShape Lifesciences® Reports Year Ended December 31, 2022..